Title 21Food and DrugsRelease 119-73not60

§2331 Director of National Intelligence Program on Use of Intelligence Resources in Efforts to Sanction Foreign Opioid Traffickers

Title 21 › Chapter 28— SANCTIONS WITH RESPECT TO FOREIGN TRAFFICKERS OF ILLICIT SYNTHETIC OPIOIDS › Subchapter II— OTHER MATTERS › § 2331

Last updated Apr 5, 2026|Official source

Summary

Requires the Director of National Intelligence to run a program, with the Director of the Office of National Drug Control Policy, that uses intelligence collection and analysis to help the Treasury, State, and the DEA find and sanction foreign opioid traffickers. When possible, the program must focus on money-related threats from drug trafficking and be created with input from Treasury terrorism and financial crimes officials, Treasury intelligence, FinCEN, and suitable federal law enforcement agencies. The Director must also review counternarcotics intelligence priorities to see if they match the scale of U.S. drug deaths. Within 90 days after December 20, 2019, and yearly after that, the Director and the ONDCP Director must report to Congress on the program’s status and achievements (the first report must list intelligence community spending for fiscal years 2017 and 2018). They must brief Congress every six months. Within 120 days after December 20, 2019, the Director must give Congress the review results and say whether priority changes are needed. Intelligence community — the group of agencies defined in Title 50, section 3003(4).

Full Legal Text

Title 21, §2331

Food and Drugs — Source: USLM XML via OLRC

(a)(1)The Director of National Intelligence shall, in consultation with the Director of the Office of National Drug Control Policy, carry out a program to allocate and enhance use of resources of the intelligence community, including intelligence collection and analysis, to assist the Secretary of the Treasury, the Secretary of State, and the Administrator of the Drug Enforcement Administration in efforts to identify and impose sanctions with respect to foreign opioid traffickers under subchapter I.
(2)To the extent practicable, efforts described in paragraph (1) shall—
(A)take into account specific illicit finance risks related to narcotics trafficking; and
(B)be developed in consultation with the Undersecretary of the Treasury for Terrorism and Financial Crimes, appropriate officials of the Office of Intelligence and Analysis of the Department of the Treasury, the Director of the Financial Crimes Enforcement Network, and appropriate Federal law enforcement agencies.
(b)The Director of National Intelligence shall, in coordination with the Director of the Office of National Drug Control Policy, carry out a comprehensive review of the current intelligence collection priorities of the intelligence community for counternarcotics purposes in order to identify whether such priorities are appropriate and sufficient in light of the number of lives lost in the United States each year due to use of illegal drugs.
(c)(1)(A)Not later than 90 days after December 20, 2019, and annually thereafter, the Director of National Intelligence and the Director of the Office of National Drug Control Policy shall jointly submit to the appropriate congressional committees and leadership a report on the status and accomplishments of the program required by subsection (a) during the year ending on the date of the report. The first report under this subparagraph shall also include a description of the amount of funds devoted by the intelligence community to the efforts described in subsection (a) during each of fiscal years 2017 and 2018.
(B)On a semiannual basis, the Director of National Intelligence and the Director of the Office of National Drug Control Policy shall jointly brief the appropriate congressional committees and leadership on the status and accomplishments of the program required by subsection (a).
(2)Not later than 120 days after December 20, 2019, the Director of National Intelligence, in consultation with the Director of the Office of National Drug Control Policy and other relevant agencies, shall submit to the appropriate congressional committees and leadership—
(A)a comprehensive description of the results of the review required by subsection (b); and
(B)an assessment of whether—
(i)the priorities described in that subsection are appropriate and sufficient in light of the number of lives lost in the United States each year due to use of illegal drugs; and
(ii)any changes to such priorities are necessary.
(d)In this section, the term “intelligence community” has the meaning given that term in section 3003(4) of title 50.

Legislative History

Notes & Related Subsidiaries

Editorial Notes

References in Text

Subchapter I, referred to in subsec. (a)(1), was in the original “subtitle A”, meaning subtitle A (§§ 7211–7217) of title LXXII of div. F of Pub. L. 116–92, which is classified principally to subchapter I of this chapter. For complete classification of subtitle A to the Code, see Tables.

Amendments

2022—Subsec. (c). Pub. L. 117–263, § 6811(h)(1), inserted “and briefings” after “Reports” in heading. Subsec. (c)(1). Pub. L. 117–263, § 6811(h)(2), substituted “Reports and briefings on program” for “Quarterly reports on program” in par. heading; designated existing provisions as subpar. (A) and inserted subpar. heading; in subpar. (A), substituted “annually” for “every 90 days”, “year” for “90-day period”, and “under this subparagraph” for “under this paragraph”; and added subpar. (B).

Reference

Citations & Metadata

Citation

21 U.S.C. § 2331

Title 21Food and Drugs

Last Updated

Apr 5, 2026

Release point: 119-73not60